Filing Details
- Accession Number:
- 0001127602-12-010517
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-13 14:55:54
- Reporting Period:
- 2012-03-09
- Filing Date:
- 2012-03-13
- Accepted Time:
- 2012-03-13 14:55:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1499098 | Joseph Avellone | Parexel International Corporation 195 West Street Waltham MA 02451 | Corp. Senior Vp Crs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-09 | 5,075 | $21.97 | 26,775 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-03-09 | 10,963 | $20.01 | 37,738 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-03-09 | 2,987 | $23.06 | 40,725 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-03-09 | 12,500 | $13.00 | 53,225 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-03-09 | 6,250 | $9.12 | 59,475 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-09 | 37,775 | $25.22 | 21,700 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-03-09 | 5,075 | $0.00 | 5,075 | $21.97 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-03-09 | 10,963 | $0.00 | 10,963 | $20.01 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-03-09 | 2,987 | $0.00 | 2,987 | $23.06 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-03-09 | 12,500 | $0.00 | 12,500 | $13.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-03-09 | 6,250 | $0.00 | 6,250 | $9.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,225 | 2018-09-15 | No | 4 | M | Direct | |
| 0 | 2015-05-24 | No | 4 | M | Direct | |
| 0 | 2015-12-20 | No | 4 | M | Direct | |
| 12,500 | 2017-12-09 | No | 4 | M | Direct | |
| 6,250 | 2017-03-20 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $24.99- $25.45. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
- Options become exercisable in 4 annual increments of 25% of the total grant, commencing on the first anniversary of the date of grant.
- Currently exercisable
Billionaire Hedge Funds
